Artisafe L 40mg/240mg Tablet DT

Name: Artisafe L 40mg/240mg Tablet DT
Brand: Alkem Laboratories Ltd
Price: 74 INR

Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Artemether (40mg) + Lumefantrine (240mg)

Overview Artisafe L 40mg/240mg Tablet DT

Malarone L (40 mg/240 mg) tablets are indicated for treating malaria in patients of all ages. This combination antimalarial medication targets malaria parasites, halting infection progression. It's ineffective against severe malaria affecting vital organs (brain, lungs, kidneys) or for malaria prevention. Optimal absorption necessitates ingestion with food. Adhere strictly to your physician's prescribed dosage and duration; exceeding the recommended dose poses health risks. Complete the entire course for effective treatment. Common side effects include headache, decreased appetite, fatigue, arthralgia, and myalgia; dizziness may also occur. Report persistent or worsening symptoms to your doctor. Disclose all other medications to your doctor prior to commencing treatment. Use during pregnancy or breastfeeding requires explicit medical authorization due to potential fetal harm.

Uses of Artisafe L 40mg/240mg Tablet DT

Managing Malaria Infection

Major Benefits of Artisafe L 40mg/240mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Artisafe L 40 mg/240 mg Tablet DT in water before consumption. It should be taken with a meal.

Common Side effects of Artisafe L 40mg/240mg Tablet DT:

Headache
Loss of appetite
Dizziness
Weakness
Joint pain
Muscle pain

How to use Artisafe L 40mg/240mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve one tablet in water before consumption. Always take Artisafe L 40 mg/240 mg Delayed-Release Tablets with food.

How Artisafe L 40mg/240mg Tablet DT works:

Artemether and lumefantrine, combined as Artisafe L 40 mg/240 mg Delayed-Release Tablets, provide effective malaria treatment. Their mechanism involves elevating blood heme concentrations, a toxin to the malaria parasite, thus eliminating the parasite and halting infection progression.

SAFETY ADVICE

AlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Artisafe L 40 mg/240 mg Tablet DT is not established as safe. Seek medical advice before combining them.

PregnancyCONSULT YOUR DOCTOR

Use of Artisafe L 40 mg/240 mg Delayed-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.

Breast feedingSAFE IF PRESCRIBED

Lactation and Artisafe L 40 mg/240 mg DT tablets appear compatible. Available human data indicates minimal infant risk associated with maternal use.

DrivingUNSAFE

Taking Artisafe L 40 mg/240 mg Delayed-Release Tablets may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyCAUTION

The use of Artisafe L 40 mg/240 mg extended-release tablets requires careful consideration in individuals with severely impaired kidney function. Dosage modification for Artisafe L 40 mg/240 mg extended-release tablets might be necessary. Physician consultation is advised. However, altering the dosage is not typically advised for patients with severe kidney disease.

LiverCAUTION

The use of Artisafe L 40 mg/240 mg Tablet DT requires careful consideration in individuals with severe hepatic impairment. A modified dosage of Artisafe L 40 mg/240 mg Tablet DT might be necessary. Physician consultation is advised. Dosage alterations are not typically advised for patients exhibiting severe hepatic dysfunction.

What if you forget to take Artisafe L 40mg/240mg Tablet DT :

Should you forget a dose of Artisafe L 40 mg/240 mg Delayed-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Artisafe L 40mg/240mg Tablet DT

Label	Value
Addictive	None.
Medication Classification	Antimalarial medications

FAQs on Artisafe L 40mg/240mg Tablet DT

Consume Artisafe L 40 mg/240 mg delayed-release tablets with meals, adhering precisely to your physician's instructions. The typical regimen involves twice-daily administration with food for three days. Begin treatment by taking the initial dose with a meal, followed by a second dose eight hours later. Subsequently, for the remaining two days, administer one dose in the morning and one in the evening. Patients should be advised to return to their regular diet as soon as possible, as this enhances medication absorption.

Use of Artisafe L 40 mg/240 mg Tablet DT is discouraged during the first three months of pregnancy due to an elevated risk of miscarriage.

Patients exhibiting hypersensitivity to any component of Artisafe L 40 mg/240 mg Tablet DT should avoid its use. The medication warrants careful consideration in individuals with severe malaria and during the initial three months of pregnancy.

This medication should remain in its original, tightly sealed container. Children must be prevented from accessing it. Room temperature storage, away from excessive heat and dampness, is recommended.

MRP 86

13% off

Inclusive of all taxes

Quantity:

of 6 Tablet dt

Artisafe L 40mg/240mg Tab...